We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$37.8B
AUM Growth
+$3.94B
Cap. Flow
+$1.54B
Cap. Flow %
4.08%
Top 10 Hldgs %
22%
Holding
1,437
New
65
Increased
570
Reduced
395
Closed
99

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$73.7M
2
LIN icon
Linde
LIN
+$68.9M
3
SHW icon
Sherwin-Williams
SHW
+$52.4M
4
MDT icon
Medtronic
MDT
+$52.2M
5
CRM icon
Salesforce
CRM
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Healthcare 19.83%
3 Financials 11.79%
4 Industrials 9.64%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COIN icon
1001
Coinbase
COIN
$39.2B
$592K ﹤0.01%
17,230
+3,050
+22% +$161K
DEI icon
1002
Douglas Emmett
DEI
$1.92B
$576K ﹤0.01%
36,712
-5,317
-13% -$88.5K
VCYT icon
1003
Veracyte
VCYT
$3.73B
$574K ﹤0.01%
24,200
TWST icon
1004
Twist Bioscience
TWST
$7.72B
$573K ﹤0.01%
25,000
EQC
1005
DELISTED
Equity Commonwealth
EQC
$573K ﹤0.01%
22,963
LBTYA icon
1006
Liberty Global Class A
LBTYA
$3.48B
$569K ﹤0.01%
29,937
+2,378
+9% +$43.3K
IMVT icon
1007
Immunovant
IMVT
$8.45B
$568K ﹤0.01%
32,600
ABUS icon
1008
Arbutus Biopharma
ABUS
$923M
$565K ﹤0.01%
250,000
KYMR icon
1009
Kymera Therapeutics
KYMR
$9.11B
$564K ﹤0.01%
22,000
RVMD icon
1010
Revolution Medicines
RVMD
$44.1B
$564K ﹤0.01%
23,800
PK icon
1011
Park Hotels & Resorts
PK
$2.89B
$563K ﹤0.01%
47,784
CSIQ icon
1012
Canadian Solar
CSIQ
$1.08B
$553K ﹤0.01%
18,020
+2,964
+20% +$99.5K
HII icon
1013
Huntington Ingalls Industries
HII
$12.9B
$551K ﹤0.01%
2,398
-1,503
-39% -$354K
UNIT
1014
Uniti Group
UNIT
$2.25B
$551K ﹤0.01%
98,600
MHK icon
1015
Mohawk Industries
MHK
$9.26B
$546K ﹤0.01%
5,386
-10,699
-67% -$1.05M
RNAM
1016
DELISTED
Avidity Biosciences
RNAM
$544K ﹤0.01%
+24,000
New +$358K
AGIO icon
1017
Agios Pharmaceuticals
AGIO
$1.95B
$542K ﹤0.01%
20,000
LEGN icon
1018
Legend Biotech
LEGN
$4.22B
$532K ﹤0.01%
10,734
-3,098
-22% -$150K
CLF icon
1019
Cleveland-Cliffs
CLF
$7.08B
$531K ﹤0.01%
32,479
+893
+3% +$13.4K
SMMT icon
1020
Summit Therapeutics
SMMT
$12.1B
$531K ﹤0.01%
+100,000
New +$182K
CASY icon
1021
Casey's General Stores
CASY
$30.7B
$529K ﹤0.01%
2,339
SHG icon
1022
Shinhan Financial Group
SHG
$34.3B
$529K ﹤0.01%
18,773
MAC icon
1023
Macerich
MAC
$6.96B
$525K ﹤0.01%
47,529
RGA icon
1024
Reinsurance Group of America
RGA
$16B
$523K ﹤0.01%
3,687
-293
-7% -$40.9K
AKYA
1025
DELISTED
Akoya BioSciences
AKYA
$522K ﹤0.01%
+55,000
New +$677K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2022 Portfolio in Review

As of Q4 2022, DekaBank Deutsche Girozentrale held 1,437 positions worth $37.8B, up 12% from $33.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.54B of net new capital in Q4 2022, opening 65 new positions and adding to 570 existing holdings. Its largest new stake was Wolfspeed: 120,839 shares worth $8.28M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $73.7M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2022 buy was Wolfspeed: 120,839 shares worth $8.28M.
  • DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q4 2022, an estimated $186M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $73.7M.
  • DekaBank Deutsche Girozentrale fully exited Duke Realty Corp. in Q4 2022, selling an estimated $16.3M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 22% of its $37.8B portfolio in Q4 2022.
  • DekaBank Deutsche Girozentrale opened 65 new positions and closed 99 in Q4 2022.
  • DekaBank Deutsche Girozentrale's portfolio value rose 12% quarter-over-quarter to $37.8B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.